Last reviewed · How we verify
NCT04571541
Endoscopic Management of Esophageal Wall Defects
trial testing Stenting in Esophageal Fistula in 150 participants. Completed in 1 July 2025.
1 July 2025
Quick facts
| Lead sponsor | Indiana University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 July 2014 |
| Primary completion | 1 July 2025 |
| Estimated completion | 1 July 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Stenting
Conditions studied
- Esophageal Fistula — all drugs for Esophageal Fistula →
- Esophageal Perforation — all drugs for Esophageal Perforation →
Sponsor
Indiana University
Who can join
Eligibility, any sex, with Esophageal Fistula or Esophageal Perforation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aim at comparing outcomes from the implementation of various endoscopic closure techniques including stenting and suturing on the healing and resolution of esophageal wall defects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04571541
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stenting
Trials testing the same drug.
- NCT07010354 — An Observational Study to Evaluate Safety, Performance, and Clinical Benefit of BeFlow · recruiting
- NCT04192760 — Culotte Versus DK-CRUSH Technique in Non-left Main Coronary Bifurcation Lesions · NA · unknown
- NCT03770650 — IVUS-guided DK Crush Stenting Technique for Patients With Complex Bifurcation Lesions · NA · active not recruiting
- NCT01816854 — Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent · completed
- NCT01270139 — Plasmonic Nanophotothermal Therapy of Atherosclerosis · NA · completed
Other Indiana University trials
Trials by the same sponsor.
- NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
- NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
- NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
- NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
- NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04571541 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indiana University
- Last refreshed: 18 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04571541.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing